LexDanaLexDanabeta
Inventor

Xiaoting Zhai

Inventor
Suzhou, CN

Overview

4→
Patents
2019–2021
Patent span
Chemistry
Primary field (CPC C)

Patents· 4 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations25%
C07BGeneral methods of organic chemistry25%
C07DHeterocyclic compounds25%
A61KPreparations for medical, dental or toiletry purposes17%
E21BEarth or rock drilling8%
PatentTitleYear
11,117,876Crystalline form of ozanimod hydrochloride, and processes for preparation thereof202111,111,223Crystalline forms of ozanimod and ozanimod hydrochloride, and processes for preparation thereof202111,066,384Crystalline forms of ARN-509, preparation method and use thereof202110,458,207Reduced-physics, data-driven secondary recovery optimization2019

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2019Patents assigned to QRI GROUP LLC (1)· patent assignee history
2019Based in Houston, TX, US· patent location history
2021Patents assigned to RECEPTOS LLC (2)· patent assignee history
2021Patents assigned to CRYSTAL PHARMACEUTICAL SUZHOU CO LTD (1)· patent assignee history
2021Based in Suzhou, CN· patent location history
2021Based in Jiangsu, CN· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
RECEPTOS LLC22021
CRYSTAL PHARMACEUTICAL SUZHOU CO LTD12021
QRI GROUP LLC12019
Locations
LocationPatentsSpan
Suzhou, CN22021
Jiangsu, CN12021
Houston, Texas, US12019